For instance, lncRNA SBF2-AS1 was recently revealed to modulate cell proliferation of AML cells through acting as a miRNA sponge of miR-188-5p, and SBF2-AS1 inhibition represents a potential therapeutic strategy for AML treatment (Tian et al., 2019[26]). This evidence concerns the gene SBF2 and acute myeloid leukemia.